Patent ID: 8476285
Filing Date: 2013-07-02
Classification: A61K,A61P,C07D

Abstract:
1. A pharmaceutical composition comprising: a pharmaceutically acceptable carrier and an effective amount of a compound of Formula I, or a pharmaceutically acceptable salt thereof, wherein: A is chosen from a substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carbocyclic group; B is chosen from a substituted or unsubstituted piperidine, homopiperidine, piperazine, pyrrolidine or azetidine group; R1 is chosen from hydro, alkyl, aryl, heteroaryl, amino, or halo; L is independently chosen from 0, 1, 2, 3, 4, 5, 6, 7 or 8, and wherein each carbon and/or nitrogen can be optionally substituted with one or more substituents independently chosen from hydroxyl, halo, alkoxy, C L independently chosen from 0, 1, 2, 3, 4, 5, 6, 7 or 8, and wherein each carbon and/or nitrogen can be optionally substituted with one or more substituents independently chosen from hydroxyl, halo, alkoxy, C